What would you be doing if
back pain wasn't an issue?

What would you be doing if back pain wasn't an issue?

Welcome to Companion Spine.

The pain-treating, motion preserving precision spine care company

In the United States alone, there more than 10 million cases reported of spinal stenosis and degenerative disc disease. If you’re one of them, you know how uncomfortable and painful either can be. Companion Spine is the first company fully dedicated to the interventional treatment of back pain. The company is focused on a “toolbox” of technologies that match a precise treatment to a patient’s condition.

Early diagnoses = more effective interventions.

With a portfolio of tools and technologies, we can identify the severity, location and nature of spinal disease, and provide solutions to treat these conditions with minimally invasive or non-invasive alternatives. The goal is to ensure that patients maintain mobility and spinal function to live a full and healthy life.

Over the coming months, Companion Spine will be introducing implantable devices for lower back pain. These announcements will follow all commercial and regulatory approvals, which are underway.

Let’s reimagine
spine health.

Imagine if we could precisely help identify the root causes of spine pain – and pinpoint the biomechanical and biological factors that induce pain, to correctly assess the nature and advancement of spinal disease.

This would enable treatment solutions that pain management physicians and spine surgeons could recommend to patients for the earliest and most effective interventions – and prevent needless irreversible surgeries in the long run.

Let’s reimagine spine health.

Changing spine care for good.

All of Companion Spine’s tools and technologies are designed to provide simple and complete therapeutic solutions to back pain and its related effects, including leg pain, long-term disability, and even unnecessary reliance on medications.

Over the coming months, Companion Spine will be introducing revolutionary technology for the early diagnosis of back pain causes. These announcements will follow all commercial and regulatory approvals, which are underway.